$SNPS

SYNOPSYS INC (SNPS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SYNOPSYS INC (SNPS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 12, 2026, Synopsys, Inc. (“ Synopsys ”) announced that Janet Lee will no longer serve as Synopsys’ General Counse

Original reporting
Published Aug 12, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 1:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SNPS
Neutral
medium confidence
Mentioned
$SNPS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

Janet Lee will stop serving as General Counsel and Corporate Secretary, moving to an advisory role until June 30, 2027 or later as determined by Synopsys, with an earlier effective date if a successor is appointed.

02

Market read

This is a governance and succession disclosure with a defined transition timeline, but no stated legal or financial shock in the text.

03

What to watch

Traders may want to watch for any later 8-K naming the successor and any concurrent changes to legal/compliance posture, especially if there are ongoing investigations not mentioned here.

Relevance 6/10Novelty 5/10Timing: today’s SEC 8-K filing, with effective date tied to Dec. 31, 2026 or successor appointment

Background

The filing is an SEC Form 8-K (Item 5.02) reporting the departure of a senior officer and related compensatory arrangements.

Company-level read

Ticker impact

$SNPSNeutralMedium confidence
Context

Synopsys disclosed in an 8-K that Janet Lee will step down as General Counsel and Corporate Secretary, effective the earlier of Dec. 31, 2026 or successor appointment.

Expected impact

Likely limited near-term impact; any repricing would depend on whether the successor is announced and whether the market views the transition as routine.

Evidence & confidence

The disclosure is a scheduled departure with an advisory transition period, and it does not include litigation, regulatory findings, or material financial terms.

Market effects

Minimal sector read-through; this is company-specific governance/leadership succession rather than a software-industry catalyst.

No clear regional spillover beyond US large-cap governance sentiment.

Low; the event is not tied to global regulatory actions, major contracts, or cross-border operations in the text.

Counterpoint

The transition could be routine succession planning, so the market may largely ignore it until the successor is named.

Key entities

  • Synopsys, Inc.

    US software company filing the 8-K reporting an officer departure and transition plan.

  • Janet Lee

    Outgoing General Counsel and Corporate Secretary, transitioning to an advisory role through mid-2027.

  • Shelagh Glaser

    CFO signing the 8-K on behalf of Synopsys.

Related articles

$SNPSMedAI 8/10

Why Has Synopsys Stopped Leading With Bad News?

Synopsys (SNPS) shifted its earnings call focus from past issues, like China's export restrictions and IP business underperformance, to new growth areas like Multiphysics Fusion with Ansys and agentic AI. Design Automation grew to $7.7-7.9B, while Design IP remained at $1.8B. Management expects new initiatives to boost EDA growth in 2027, but Design IP's turnaround is based on a single quarter of growth.

$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.